Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
FBIO
#3975
Fortress Biotech, Inc. - Common Stock
2.7
7
USD
-0.01%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-1.07%
Monthly Change
-18.05%
6 month change
-14.77%
Year Change
+12.60%
Previous Close
2.8
0
Open
2.7
8
Low
2.7
6
High
2.8
0
Volume
46
Markets
US Stock Market
Healthcare
Biotechnology
FBIO
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Documents
2024
Current report, Q2 FY2024
2024.06.25
Fortress Biotech, Inc. current report, Q2 FY2024
8-K
1
2
3
4
5
News
Fortress Biotech, Inc. (FBIO) Q2 2026 Earnings Call Transcript
Fortress Biotech: Cash Above Market Cap And Royalty Upside Make This A Speculative Buy
Fortress Biotech: Is It Time To Pay The Deferred Preferred Stock Dividends? (FBIO)
Avenue Therapeutics licenses ATX-04 for Pompe disease treatment
Fortress Biotech Stock: The PRV Catalyst That Could Reprice This Microcap (NASDAQ:FBIO)
Cigna Q4 Earnings Beat Estimates on Higher Specialty Volumes
Elevance Health Q4 Earnings Beat Estimates on Increasing Premiums
Centene Expands Palliative Care Access in Ohio Through Tuesday Health
FDA approves first treatment for Menkes disease in children
FDA sets new PDUFA date for Fortress Biotech’s Menkes disease therapy
Fortress Biotech (FBIO) Surpasses Q3 Earnings Estimates
Fortress Biotech, Inc. (FBIO) Q3 2025 Earnings Call Transcript